COVID-19

Here's the coronavirus-related news you should know from this week.

Despite some anticipated hesitancy, demand for the novel coronavirus vaccine will be significant when it becomes available.

The campaign advocates for improvements to the next COVID-19 relief package, including expanded protections and roles for community pharmacists.

Pfizer and BioNTech SE announced that 2 of its most successful vaccine candidates received Fast Track designation from the FDA, opening the avenue for speedy development.

The therapy will also be available for individuals with asthma and suspected COVID-19 infection.

Moderna announced interim analysis results of its investigational COVID-19 vaccine candidate, mRNA-1273, from an ongoing phase 1 study.

Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.

Dr. Cheryl Wisseh, PharmD, zone 5 director of the National Pharmaceutical Association (NPhA) discusses the ways that the current pandemic is displaying and doubling down on long standing disparities in our health care system.

Here's the coronavirus-related news you should know from this week.

Survey results on PrEP access and utilization during COVID-19 shelter-in-place orders presented at the 23rd International AIDS Conference.

Drug Topics interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.

The FDA has granted emergency use authorization to an additional combination diagnostic test for influenza and COVID-19.

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

Here's this week's roundup of the coronavirus-related news you should know.

Kroger Health will start offering its COVID-19 Test Home Collection Kit with the guidance of a telehealth consultation.

A Johns Hopkins research team has determined that tests are more likely to result in false negatives for the COVID-19 virus if taken too early in the course of infection.

In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.

An updated list of risk factors for severe COVID-19 expands possible underlying medical conditions and removes the age threshold.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

In an open letter, Gilead Chairman and CEO Daniel O’Day announced the price of remdesivir treatment for COVID-19.

Today, pharmacists are banding together to “eliminate racism, discrimination, injustice, and the marginalization of individuals within the profession.”

Vaccine candidates for COVID-19 are going through clinical trials at a faster rate than for any other disease.

Check out this week's most important coronavirus-related news.

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

Existing surveillance networks can track influenza-like illness and lead to improved assessments on impact, prevalence, and severity of COVID-19.

The MMR vaccine may demonstrate some degree of protection against septic inflammation, a symptom of COVID-19, according to a team of experts.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

A new poll by Gallup and West Health found that a majority of Americans have expressed numerous health care system-related concerns, including rising costs of drugs, insurance premiums, and health care in response to COVID-19.

Amie Blaszczyk, PharmD, FASHP, CGP, BCPS, associate professor and division head of geriatrics at Texas Tech University Health Sciences Center, explains the factors acting on older adults in long term care, and the response from these facilities.